Trial Profile
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR [controlled-release] For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jun 2008
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Jun 2008 New trial record.